Joy Scheidell
Joy D. Scheidell, PhD, MPH
University of Central Florida - Assistant Professor, Department of Health Sciences
PhD, Epidemiology, New York University
MPH, Epidemiology, University of Florida
BS, Community Health, Florida Gulf Coast University
Research Interests
Sexual and reproductive health, criminal justice involvement, substance use, mental health, health inequities
Joy Scheidell is an epidemiologist and Assistant Professor in the Department of Health Sciences at the University of Central Florida. She received her PhD in Epidemiology from NYU and an MPH in Epidemiology from the University of Florida. She is a former predoctoral fellow of the NIDA-funded Behavioral Sciences Training in Drug Abuse Research Program (T32 DA7233) and scholar in the NIDA Diversity Scholars Network 2022 cohort. Dr. Scheidell’s research seeks to understand the intersections of mental health, substance use, and sexual and reproductive health, with a specific focus on vulnerable and marginalized populations. In addition to conducting her research, Dr. Scheidell is a devoted instructor of epidemiologic and population health research methods.
Principal Investigator, Drug Treatment as Disease Prevention: Reducing Sexually Transmitted Infection Risk among Women Who Use Drugs. Active
Principal Investigator, Influence of Substance Use Treatment and Harm Reduction Engagement on Sexual Health among People Who Use Illicit Opioids in New York City. Completed
Principal Investigator, Racial/Ethnic Inequities in Treatment for Women with Opioid Use Disorder and Associations with Health. Completed


Scheidell JD, Townsend TN, Zhou Q, Manandhar-Sasaki P, Rodriguez-Santana R, Jenkins M, Buchelli M, Charles DL, Frechette JM, Su JI, Braithwaite RS (2024).
Reducing overdose deaths among persons with opioid use disorder in Connecticut
Harm Reduction Journal, 21 (1), 103. doi: 10.1186/s12954-024-01026-6. PMCID: PMC11131266.

Feelemyer J, Duncan DT, Akhidenor N, Mazumdar M, Irvine NM, Scheidell JD, Brewer RA, Turpin RE, Hucks-Ortiz C, Dyer TV, Cleland CM, Mayer KH, Khan MR (2024).
Police harassment and psychiatric, sexual, and substance use risk among Black sexual minority men and Black transgender women in the HIV Prevention Trials 061 cohort
Journal of Racial and Ethnic Health Disparities [Epub 2024 Apr 12]. doi: 10.1007/s40615-024-01909-1.

Feelemyer J, Bershteyn A, Scheidell JD, Brewer R, Dyer TV, Cleland CM, Hucks-Ortiz C, Justice A, Mayer K, Grawert A, Kaufman JS, Braithwaite S, Khan MR (2024).
Impact of decarceration plus alcohol, substance use, and mental health screening on life expectancies of Black sexual minority men and Black transgender women (BSMM/BTW) living with HIV in the United States: A simulation study based on HPTN 061
Journal of Acquired Immune Deficiency Syndromes, 95 (1), 283-290. doi: 10.1097/QAI.0000000000003354. PMCID: PMC10922416.

Scheidell JD, Elliott LC, Bennett AS, Mahachi M, Lapple D, Nelson JA, Hobbs MM (2024).
Evaluation of self-directed specimen collection for chlamydia and gonorrhea testing among people who use drugs
International Journal of STD and AIDS, 35 (3), 217-227. doi: 10.1177/09564624231215859.

Scheidell JD, Pitre M, Andraka-Christou B (2024).
Racial and ethnic inequities in substance use treatment among women with opioid use disorder
American Journal of Drug and Alcohol Abuse, 50 (1), 106-116. doi: 10.1080/00952990.2023.2291748.


Scheidell JD, Lejuez CW, Golin CE, Hobbs MM, Wohl DA, Adimora AA, Khan MR (2016).
Borderline personality disorder symptom severity and sexually transmitted infection and HIV risk in African American incarcerated men
Sexually Transmitted Diseases, 43 (5), 317-323. doi: 10.1097/OLQ.0000000000000433. PMCID: PMC4840466.

Ms. Scheidell's MyBibliography Profile